GenSight Biologics Statistics
Total Valuation
GSGTF has a market cap or net worth of 39.14 million. The enterprise value is 58.04 million.
| Market Cap | 39.14M |
| Enterprise Value | 58.04M |
Important Dates
The next estimated earnings date is Friday, September 19, 2025.
| Earnings Date | Sep 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +98.18% |
| Shares Change (QoQ) | +31.43% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 89.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.40 |
| PB Ratio | -1.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.00 |
| EV / Sales | 19.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.33 |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.48 |
| Interest Coverage | -10.18 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -99.39% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 133.32% |
| Revenue Per Employee | 169,855 |
| Profits Per Employee | -905,956 |
| Employee Count | 16 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.94% in the last 52 weeks. The beta is 2.25, so GSGTF's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | -48.94% |
| 50-Day Moving Average | 6.02 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 28.66 |
| Average Volume (20 Days) | 1,703 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSGTF had revenue of 2.72 million and -14.50 million in losses. Loss per share was -0.15.
| Revenue | 2.72M |
| Gross Profit | 2.72M |
| Operating Income | -16.37M |
| Pretax Income | -14.47M |
| Net Income | -14.50M |
| EBITDA | -16.21M |
| EBIT | -16.37M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 2.55 million in cash and 19.79 million in debt, giving a net cash position of -17.24 million.
| Cash & Cash Equivalents | 2.55M |
| Total Debt | 19.79M |
| Net Cash | -17.24M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -27.87M |
| Book Value Per Share | -0.22 |
| Working Capital | -17.88M |
Cash Flow
In the last 12 months, operating cash flow was -13.39 million and capital expenditures -1,035, giving a free cash flow of -13.39 million.
| Operating Cash Flow | -13.39M |
| Capital Expenditures | -1,035 |
| Free Cash Flow | -13.39M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -602.44% |
| Pretax Margin | -532.57% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GSGTF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -98.18% |
| Shareholder Yield | -98.18% |
| Earnings Yield | -37.03% |
| FCF Yield | -34.22% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GSGTF has an Altman Z-Score of -7.81. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.81 |
| Piotroski F-Score | n/a |